Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in App^{NL-G-F/NL-G-F} mice.

ABSTRACT: Sustained microglial activation and increased pro-inflammatory signalling cause chronic inflammation and neuronal damage in Alzheimer's disease (AD). Resolution of inflammation follows neutralization of pathogens and is a response to limit damage and promote healing, mediated by pro-resolving lipid mediators (LMs). Since resolution is impaired in AD brains, we decided to test if intranasal administration of pro-resolving LMs in the App^{NL-G-F/NL-G-F} mouse model for AD could resolve inflammation and ameliorate pathology in the brain. A mixture of the pro-resolving LMs resolvin (Rv) E1, RvD1, RvD2, maresin 1 (MaR1) and neuroprotectin D1 (NPD1) was administered to stimulate their respective receptors. We examined amyloid load, cognition, neuronal network oscillations, glial activati

SUBMITTER: Emre C 

PROVIDER: S-EPMC8938447 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature